QT Imaging (NASDAQ:QTI) Announces Quarterly Earnings Results

QT Imaging (NASDAQ:QTI) announced its quarterly earnings results on Wednesday. The company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.03, Zacks reports. QT Imaging had a negative net margin of 58.93% and a negative return on equity of 4,220.38%.

Here are the key takeaways from QT Imaging’s conference call:

• Second-quarter revenue more than doubled year over year to $7.4 million, driven by 15 scanner shipments versus eight in the prior-year period. First-half revenue reached $14 million on 28 shipments, and management reaffirmed approximately $39 million in 2026 revenue guidance.
• QT Imaging expanded its commercial and international infrastructure, adding U.S. regional sales leadership and securing regulatory authorization in Saudi Arabia and Israel. The company expects to ship another 15 scanners in the third quarter and 17 in the fourth quarter, primarily through NXC Imaging.
• The company highlighted clinical and reimbursement progress, including a dedicated Category III CPT code effective January 1, 2027, a study at Mayo Clinic involving more than 100 patients, and evidence showing less than 1% variability in speed-of-sound measurements across scanners.
• Gross margin declined to 41% from 50% a year earlier, while operating expenses increased to $4.9 million. The net loss widened to $11.1 million, including an $8.3 million non-cash loss tied to the company’s debt amendment; the amended loan also carries a higher interest rate of 12% versus 10%.
• Management acknowledged that scanner deployment and customer utilization are progressing more slowly than desired, requiring the company to spend the next several months helping NXC Imaging place scanners with customers. Second-half operating expenses are expected to rise modestly due to sales hiring and clinical-study costs.

QT Imaging Price Performance

Shares of QTI stock traded up $0.12 on Wednesday, hitting $3.01. 61,872 shares of the stock traded hands, compared to its average volume of 43,948. The firm has a market cap of $41.44 million, a price-to-earnings ratio of -2.43 and a beta of -0.01. QT Imaging has a 52 week low of $1.82 and a 52 week high of $8.50. The firm has a 50 day simple moving average of $3.48 and a two-hundred day simple moving average of $5.17. The company has a debt-to-equity ratio of 1.38, a current ratio of 2.49 and a quick ratio of 1.69.

Analyst Upgrades and Downgrades

A number of analysts recently commented on QTI shares. Zacks Research upgraded QT Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Wall Street Zen upgraded shares of QT Imaging to a “hold” rating in a research report on Saturday, May 16th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of QT Imaging in a report on Friday, July 10th. One analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

QT Imaging Company Profile

QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.

QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.